Table 3. Comparison of baseline and endline results.
| Agam District | Depok City | Total | ||||
|---|---|---|---|---|---|---|
| Baseline | Endline | Baseline | Endline | Baseline | Endline | |
| N = total sample | ||||||
| Have ever received the LF drug during MDA | 80.6% | 100%* | 76.3% | 76.9% | 78.4% | 88%* |
| N = individuals who had ever received LF drugs during MDA | ||||||
| Have ever taken the LF drug during MDA | 86.1% | 92.1%* | 72.3% | 88.1%* | 79.3% | 90.4%* |
| Received LF drug during last MDA | 68.7% | 90.8%* | 69.7% | 73.8% | 69.2% | 82%* |
| Took the LF drug in the last MDA | 66.6% | 84.1%* | 48.2% | 67.3%* | 57.3% | 77%* |
| Aware of MDA before receiving drugs | 71% | 85.8%* | 67% | 85.6%* | 69.1% | 85.7%* |
| Knew someone in the house that had taken LF drugs | 75% | 84.6%* | 69.4% | 81.9%* | 72.3% | 83.5%* |
| LF drugs perceived as safe | 73% | 71.9% | 62% | 66.9% | 67.62% | 69.79% |
| Taking LF drugs perceived to be important for health | 85% | 86.4% | 76.8% | 88.9%* | 81.0% | 87.5%* |
| Reported to have swallowed all of the LF drugs at once | 71.6% | 82.1%* | 53% | 66.7%* | 62.5% | 75.4%* |
| Not having enough information as the reason cited for noncompliance | 18.5% | 14.8% | 19.9% | 8.6% | 19.4% | 10.9% |
*Change in percentage where p<0.05